JoelRobertPekowMD
Gastroenterology • Chicago, ILAssociate Professor, Medicine, University of Chicago Div of the Bio Sci The Pritzker SOM
Dr. Pekow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-702-2182
Education & Training
University of ChicagoFellowship, Gastroenterology, 2007 - 2010
Massachusetts General HospitalResidency, Internal Medicine, 2003 - 2006
University of Illinois College of MedicineClass of 2003
Certifications & Licensure
IL State Medical License 2006 - 2026
MA State Medical License 2005 - 2007
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- Real-World Effectiveness and Safety of Upadacitinib in Crohn's disease: A Multi-Centre Study.Jalpa Devi, Anthony Xu, Molly Stone, Anish Patel, Abdul Khan
Clinical Gastroenterology and Hepatology. 2025-03-07 - Mirikizumab in the Treatment of Ulcerative Colitis: Initial Real-World Data in a Population from a Large Tertiary Center.Joëlle St-Pierre, David Choi, Evan Fear, Natalie K Choi, Alex J Mathew
Digestive Diseases and Sciences. 2025-03-06 - 2 citationsEndoscopic Normalization and Transition of J-Pouch Phenotypes Over Time in Patients With Inflammatory Bowel Disease.Shintaro Akiyama, Jacob E Ollech, Nathaniel A Cohen, Cindy Traboulsi, Victoria Rai
Inflammatory Bowel Diseases. 2025-01-06
Journal Articles
- Correction to: Risk Factors for Clostridium Difficile Isolation in Inflammatory Bowel Disease: A Prospective StudySushila Dalal, Vijaya L Rao, Laura R Glick, Russell Cohen, Ayal Hirsch, Dejan Micic, Joel Pekow, Atsushi Sakuraba, David T Rubin, Digestive Diseases and Sciences
Authored Content
- Effectiveness of Ustekinumab Dose Escalation in Crohn's PatientsFebruary 2020
Press Mentions
Fecal Transplant with Anti-Inflammatory Diet Yields Remissions in UCAugust 18th, 2022- Fecal Transplant with Anti-Inflammatory Diet Produces Remissions in UC -News ForestAugust 18th, 2022
- The Pros and Cons of Biologics for Ulcerative ColitisJuly 2nd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
